Additionally, the positivity rate of anti-neuronal autoantibodies (e.g., anti-glutamate receptor antibodies, GAD antibodies, etc.)is higher in epilepsy patients of unknown etiology compared to the general population, supporting the notion that a subset of epilepsies may have an autoimmune-inflammatory basis. The gene discussed is GAD1; the disease is epilepsy.